240 related articles for article (PubMed ID: 20025212)
1. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
[TBL] [Abstract][Full Text] [Related]
2. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
3. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel, non-acidic mPGES-1 inhibitors by virtual screening with a multistep protocol.
Noha SM; Fischer K; Koeberle A; Garscha U; Werz O; Schuster D
Bioorg Med Chem; 2015 Aug; 23(15):4839-4845. PubMed ID: 26088337
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
6. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
Korotkova M; Jakobsson PJ
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
[TBL] [Abstract][Full Text] [Related]
7. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.
Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY
Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602
[TBL] [Abstract][Full Text] [Related]
8. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.
He S; Li C; Liu Y; Lai L
J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E₂ synthase-1 inhibitors.
Shiro T; Takahashi H; Kakiguchi K; Inoue Y; Masuda K; Nagata H; Tobe M
Bioorg Med Chem Lett; 2012 Jan; 22(1):285-8. PubMed ID: 22137787
[TBL] [Abstract][Full Text] [Related]
10. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
11. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).
Rörsch F; Buscató E; Deckmann K; Schneider G; Schubert-Zsilavecz M; Geisslinger G; Proschak E; Grösch S
J Med Chem; 2012 Apr; 55(8):3792-803. PubMed ID: 22449023
[TBL] [Abstract][Full Text] [Related]
13. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
Koeberle A; Werz O
Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
[TBL] [Abstract][Full Text] [Related]
14. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
[TBL] [Abstract][Full Text] [Related]
16. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models.
Bauer J; Waltenberger B; Noha SM; Schuster D; Rollinger JM; Boustie J; Chollet M; Stuppner H; Werz O
ChemMedChem; 2012 Dec; 7(12):2077-81. PubMed ID: 23109349
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.
Riendeau D; Aspiotis R; Ethier D; Gareau Y; Grimm EL; Guay J; Guiral S; Juteau H; Mancini JA; Méthot N; Rubin J; Friesen RW
Bioorg Med Chem Lett; 2005 Jul; 15(14):3352-5. PubMed ID: 15953724
[TBL] [Abstract][Full Text] [Related]
18. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]